nodes	percent_of_prediction	percent_of_DWPC	metapath
Cephalexin—ALB—Auranofin—psoriatic arthritis	0.324	0.371	CbGbCtD
Cephalexin—ALB—Prednisone—psoriatic arthritis	0.103	0.118	CbGbCtD
Cephalexin—SLC22A8—Methotrexate—psoriatic arthritis	0.0872	0.0998	CbGbCtD
Cephalexin—SLC22A6—Methotrexate—psoriatic arthritis	0.0608	0.0695	CbGbCtD
Cephalexin—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0534	0.0611	CbGbCtD
Cephalexin—ALB—Methotrexate—psoriatic arthritis	0.0518	0.0592	CbGbCtD
Cephalexin—CYP3A4—Triamcinolone—psoriatic arthritis	0.0404	0.0463	CbGbCtD
Cephalexin—CYP3A4—Betamethasone—psoriatic arthritis	0.0347	0.0397	CbGbCtD
Cephalexin—CYP3A4—Prednisolone—psoriatic arthritis	0.0342	0.0392	CbGbCtD
Cephalexin—CYP3A4—Prednisone—psoriatic arthritis	0.0323	0.037	CbGbCtD
Cephalexin—CYP2D6—Dexamethasone—psoriatic arthritis	0.0317	0.0363	CbGbCtD
Cephalexin—CYP3A4—Dexamethasone—psoriatic arthritis	0.0202	0.0231	CbGbCtD
Cephalexin—Aplastic anaemia—Auranofin—psoriatic arthritis	0.00413	0.0328	CcSEcCtD
Cephalexin—Eosinophilia—Auranofin—psoriatic arthritis	0.00273	0.0217	CcSEcCtD
Cephalexin—Pancytopenia—Auranofin—psoriatic arthritis	0.00262	0.0208	CcSEcCtD
Cephalexin—Neutropenia—Auranofin—psoriatic arthritis	0.00258	0.0205	CcSEcCtD
Cephalexin—Agranulocytosis—Auranofin—psoriatic arthritis	0.0023	0.0182	CcSEcCtD
Cephalexin—Angioedema—Auranofin—psoriatic arthritis	0.00176	0.014	CcSEcCtD
Cephalexin—Leukopenia—Auranofin—psoriatic arthritis	0.00172	0.0137	CcSEcCtD
Cephalexin—Arthropathy—Prednisolone—psoriatic arthritis	0.00154	0.0122	CcSEcCtD
Cephalexin—Thrombocytopenia—Auranofin—psoriatic arthritis	0.00154	0.0122	CcSEcCtD
Cephalexin—Arthropathy—Triamcinolone—psoriatic arthritis	0.00142	0.0113	CcSEcCtD
Cephalexin—Arthropathy—Methylprednisolone—psoriatic arthritis	0.00142	0.0112	CcSEcCtD
Cephalexin—Vaginal discharge—Methotrexate—psoriatic arthritis	0.0014	0.0111	CcSEcCtD
Cephalexin—Dyspepsia—Auranofin—psoriatic arthritis	0.00138	0.011	CcSEcCtD
Cephalexin—Arthropathy—Dexamethasone—psoriatic arthritis	0.00129	0.0102	CcSEcCtD
Cephalexin—Arthropathy—Betamethasone—psoriatic arthritis	0.00129	0.0102	CcSEcCtD
Cephalexin—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.00128	0.0102	CcSEcCtD
Cephalexin—Urticaria—Auranofin—psoriatic arthritis	0.00125	0.0099	CcSEcCtD
Cephalexin—Abdominal pain—Auranofin—psoriatic arthritis	0.00124	0.00985	CcSEcCtD
Cephalexin—Arthropathy—Prednisone—psoriatic arthritis	0.00112	0.0089	CcSEcCtD
Cephalexin—Pruritus—Auranofin—psoriatic arthritis	0.00111	0.00882	CcSEcCtD
Cephalexin—Blood alkaline phosphatase increased—Methylprednisolone—psoriatic arthritis	0.00107	0.00853	CcSEcCtD
Cephalexin—Diarrhoea—Auranofin—psoriatic arthritis	0.00107	0.00853	CcSEcCtD
Cephalexin—Osteoarthritis—Prednisolone—psoriatic arthritis	0.00102	0.00808	CcSEcCtD
Cephalexin—Vomiting—Auranofin—psoriatic arthritis	0.000999	0.00792	CcSEcCtD
Cephalexin—Rash—Auranofin—psoriatic arthritis	0.00099	0.00786	CcSEcCtD
Cephalexin—Dermatitis—Auranofin—psoriatic arthritis	0.000989	0.00785	CcSEcCtD
Cephalexin—Osteoarthritis—Triamcinolone—psoriatic arthritis	0.000937	0.00743	CcSEcCtD
Cephalexin—Osteoarthritis—Methylprednisolone—psoriatic arthritis	0.000935	0.00742	CcSEcCtD
Cephalexin—Nausea—Auranofin—psoriatic arthritis	0.000933	0.0074	CcSEcCtD
Cephalexin—Vaginal inflammation—Methotrexate—psoriatic arthritis	0.000852	0.00676	CcSEcCtD
Cephalexin—Osteoarthritis—Betamethasone—psoriatic arthritis	0.00085	0.00675	CcSEcCtD
Cephalexin—Osteoarthritis—Dexamethasone—psoriatic arthritis	0.00085	0.00675	CcSEcCtD
Cephalexin—Breast disorder—Methylprednisolone—psoriatic arthritis	0.000845	0.0067	CcSEcCtD
Cephalexin—Alanine aminotransferase increased—Methylprednisolone—psoriatic arthritis	0.000825	0.00654	CcSEcCtD
Cephalexin—Vaginal infection—Methotrexate—psoriatic arthritis	0.000805	0.00638	CcSEcCtD
Cephalexin—Aplastic anaemia—Methotrexate—psoriatic arthritis	0.0008	0.00635	CcSEcCtD
Cephalexin—Osteoarthritis—Prednisone—psoriatic arthritis	0.00074	0.00587	CcSEcCtD
Cephalexin—Infestation—Methylprednisolone—psoriatic arthritis	0.00072	0.00572	CcSEcCtD
Cephalexin—Infestation NOS—Methylprednisolone—psoriatic arthritis	0.00072	0.00572	CcSEcCtD
Cephalexin—Haemoglobin—Prednisolone—psoriatic arthritis	0.000708	0.00562	CcSEcCtD
Cephalexin—Haemorrhage—Prednisolone—psoriatic arthritis	0.000705	0.00559	CcSEcCtD
Cephalexin—Alanine aminotransferase increased—Prednisone—psoriatic arthritis	0.000653	0.00518	CcSEcCtD
Cephalexin—Haemoglobin—Triamcinolone—psoriatic arthritis	0.000651	0.00517	CcSEcCtD
Cephalexin—Haemoglobin—Methylprednisolone—psoriatic arthritis	0.00065	0.00516	CcSEcCtD
Cephalexin—Haemorrhage—Triamcinolone—psoriatic arthritis	0.000648	0.00514	CcSEcCtD
Cephalexin—Haemorrhage—Methylprednisolone—psoriatic arthritis	0.000647	0.00513	CcSEcCtD
Cephalexin—Hallucination—Methylprednisolone—psoriatic arthritis	0.000643	0.00511	CcSEcCtD
Cephalexin—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.000636	0.00504	CcSEcCtD
Cephalexin—Osteoarthritis—Methotrexate—psoriatic arthritis	0.000619	0.00491	CcSEcCtD
Cephalexin—Neutropenia—Prednisone—psoriatic arthritis	0.000598	0.00475	CcSEcCtD
Cephalexin—Haemoglobin—Betamethasone—psoriatic arthritis	0.000591	0.00469	CcSEcCtD
Cephalexin—Haemoglobin—Dexamethasone—psoriatic arthritis	0.000591	0.00469	CcSEcCtD
Cephalexin—Haemorrhage—Betamethasone—psoriatic arthritis	0.000588	0.00467	CcSEcCtD
Cephalexin—Haemorrhage—Dexamethasone—psoriatic arthritis	0.000588	0.00467	CcSEcCtD
Cephalexin—Hallucination—Dexamethasone—psoriatic arthritis	0.000585	0.00464	CcSEcCtD
Cephalexin—Hallucination—Betamethasone—psoriatic arthritis	0.000585	0.00464	CcSEcCtD
Cephalexin—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.000584	0.00463	CcSEcCtD
Cephalexin—Mental disorder—Methylprednisolone—psoriatic arthritis	0.000567	0.0045	CcSEcCtD
Cephalexin—Angioedema—Prednisolone—psoriatic arthritis	0.000561	0.00445	CcSEcCtD
Cephalexin—Breast disorder—Methotrexate—psoriatic arthritis	0.000559	0.00444	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Methotrexate—psoriatic arthritis	0.000557	0.00442	CcSEcCtD
Cephalexin—Convulsion—Prednisolone—psoriatic arthritis	0.000532	0.00422	CcSEcCtD
Cephalexin—Eosinophilia—Methotrexate—psoriatic arthritis	0.000529	0.0042	CcSEcCtD
Cephalexin—Angioedema—Triamcinolone—psoriatic arthritis	0.000516	0.00409	CcSEcCtD
Cephalexin—Haemoglobin—Prednisone—psoriatic arthritis	0.000515	0.00408	CcSEcCtD
Cephalexin—Angioedema—Methylprednisolone—psoriatic arthritis	0.000514	0.00408	CcSEcCtD
Cephalexin—Haemorrhage—Prednisone—psoriatic arthritis	0.000512	0.00406	CcSEcCtD
Cephalexin—Hallucination—Prednisone—psoriatic arthritis	0.00051	0.00404	CcSEcCtD
Cephalexin—Pancytopenia—Methotrexate—psoriatic arthritis	0.000508	0.00403	CcSEcCtD
Cephalexin—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000503	0.00399	CcSEcCtD
Cephalexin—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000501	0.00397	CcSEcCtD
Cephalexin—Neutropenia—Methotrexate—psoriatic arthritis	0.0005	0.00397	CcSEcCtD
Cephalexin—Convulsion—Triamcinolone—psoriatic arthritis	0.000489	0.00388	CcSEcCtD
Cephalexin—Convulsion—Methylprednisolone—psoriatic arthritis	0.000488	0.00387	CcSEcCtD
Cephalexin—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000479	0.0038	CcSEcCtD
Cephalexin—Infestation NOS—Methotrexate—psoriatic arthritis	0.000477	0.00378	CcSEcCtD
Cephalexin—Infestation—Methotrexate—psoriatic arthritis	0.000477	0.00378	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000476	0.00378	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.000473	0.00375	CcSEcCtD
Cephalexin—Angioedema—Betamethasone—psoriatic arthritis	0.000468	0.00371	CcSEcCtD
Cephalexin—Angioedema—Dexamethasone—psoriatic arthritis	0.000468	0.00371	CcSEcCtD
Cephalexin—Confusional state—Methylprednisolone—psoriatic arthritis	0.000463	0.00368	CcSEcCtD
Cephalexin—Immune system disorder—Prednisone—psoriatic arthritis	0.000463	0.00367	CcSEcCtD
Cephalexin—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000461	0.00365	CcSEcCtD
Cephalexin—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000459	0.00365	CcSEcCtD
Cephalexin—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000451	0.00358	CcSEcCtD
Cephalexin—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000451	0.00358	CcSEcCtD
Cephalexin—Mental disorder—Prednisone—psoriatic arthritis	0.000449	0.00356	CcSEcCtD
Cephalexin—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000446	0.00354	CcSEcCtD
Cephalexin—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000445	0.00353	CcSEcCtD
Cephalexin—Convulsion—Betamethasone—psoriatic arthritis	0.000444	0.00352	CcSEcCtD
Cephalexin—Convulsion—Dexamethasone—psoriatic arthritis	0.000444	0.00352	CcSEcCtD
Cephalexin—Haemoglobin—Methotrexate—psoriatic arthritis	0.00043	0.00341	CcSEcCtD
Cephalexin—Hepatitis—Methotrexate—psoriatic arthritis	0.000428	0.0034	CcSEcCtD
Cephalexin—Haemorrhage—Methotrexate—psoriatic arthritis	0.000428	0.0034	CcSEcCtD
Cephalexin—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000423	0.00335	CcSEcCtD
Cephalexin—Urethral disorder—Methotrexate—psoriatic arthritis	0.00042	0.00333	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00042	0.00333	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000419	0.00332	CcSEcCtD
Cephalexin—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000418	0.00332	CcSEcCtD
Cephalexin—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000418	0.00332	CcSEcCtD
Cephalexin—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000413	0.00327	CcSEcCtD
Cephalexin—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00041	0.00325	CcSEcCtD
Cephalexin—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00041	0.00325	CcSEcCtD
Cephalexin—Agitation—Prednisone—psoriatic arthritis	0.00041	0.00325	CcSEcCtD
Cephalexin—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000409	0.00325	CcSEcCtD
Cephalexin—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000409	0.00325	CcSEcCtD
Cephalexin—Angioedema—Prednisone—psoriatic arthritis	0.000407	0.00323	CcSEcCtD
Cephalexin—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000405	0.00322	CcSEcCtD
Cephalexin—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000405	0.00321	CcSEcCtD
Cephalexin—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000404	0.00321	CcSEcCtD
Cephalexin—Urticaria—Prednisolone—psoriatic arthritis	0.000398	0.00316	CcSEcCtD
Cephalexin—Fatigue—Triamcinolone—psoriatic arthritis	0.000397	0.00315	CcSEcCtD
Cephalexin—Fatigue—Methylprednisolone—psoriatic arthritis	0.000396	0.00314	CcSEcCtD
Cephalexin—Immune system disorder—Methotrexate—psoriatic arthritis	0.000387	0.00307	CcSEcCtD
Cephalexin—Convulsion—Prednisone—psoriatic arthritis	0.000386	0.00307	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000381	0.00302	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000381	0.00302	CcSEcCtD
Cephalexin—Arthralgia—Prednisone—psoriatic arthritis	0.00038	0.00301	CcSEcCtD
Cephalexin—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000379	0.00301	CcSEcCtD
Cephalexin—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000379	0.003	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000377	0.00299	CcSEcCtD
Cephalexin—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000376	0.00298	CcSEcCtD
Cephalexin—Mental disorder—Methotrexate—psoriatic arthritis	0.000375	0.00298	CcSEcCtD
Cephalexin—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000369	0.00293	CcSEcCtD
Cephalexin—Dyspepsia—Betamethasone—psoriatic arthritis	0.000368	0.00292	CcSEcCtD
Cephalexin—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000368	0.00292	CcSEcCtD
Cephalexin—Urticaria—Triamcinolone—psoriatic arthritis	0.000366	0.0029	CcSEcCtD
Cephalexin—Urticaria—Methylprednisolone—psoriatic arthritis	0.000365	0.0029	CcSEcCtD
Cephalexin—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000364	0.00289	CcSEcCtD
Cephalexin—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000364	0.00289	CcSEcCtD
Cephalexin—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000363	0.00288	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000361	0.00286	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000361	0.00286	CcSEcCtD
Cephalexin—Fatigue—Dexamethasone—psoriatic arthritis	0.00036	0.00286	CcSEcCtD
Cephalexin—Fatigue—Betamethasone—psoriatic arthritis	0.00036	0.00286	CcSEcCtD
Cephalexin—Nervous system disorder—Prednisone—psoriatic arthritis	0.000357	0.00283	CcSEcCtD
Cephalexin—Skin disorder—Prednisone—psoriatic arthritis	0.000353	0.0028	CcSEcCtD
Cephalexin—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000344	0.00273	CcSEcCtD
Cephalexin—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000344	0.00273	CcSEcCtD
Cephalexin—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000342	0.00271	CcSEcCtD
Cephalexin—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000342	0.00271	CcSEcCtD
Cephalexin—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000339	0.00269	CcSEcCtD
Cephalexin—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000339	0.00269	CcSEcCtD
Cephalexin—Leukopenia—Methotrexate—psoriatic arthritis	0.000334	0.00265	CcSEcCtD
Cephalexin—Urticaria—Dexamethasone—psoriatic arthritis	0.000332	0.00263	CcSEcCtD
Cephalexin—Urticaria—Betamethasone—psoriatic arthritis	0.000332	0.00263	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000332	0.00263	CcSEcCtD
Cephalexin—Dizziness—Prednisolone—psoriatic arthritis	0.000331	0.00263	CcSEcCtD
Cephalexin—Asthenia—Triamcinolone—psoriatic arthritis	0.00033	0.00262	CcSEcCtD
Cephalexin—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00033	0.00262	CcSEcCtD
Cephalexin—Abdominal pain—Betamethasone—psoriatic arthritis	0.00033	0.00262	CcSEcCtD
Cephalexin—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00033	0.00262	CcSEcCtD
Cephalexin—Body temperature increased—Betamethasone—psoriatic arthritis	0.00033	0.00262	CcSEcCtD
Cephalexin—Asthenia—Methylprednisolone—psoriatic arthritis	0.00033	0.00262	CcSEcCtD
Cephalexin—Pruritus—Triamcinolone—psoriatic arthritis	0.000326	0.00259	CcSEcCtD
Cephalexin—Pruritus—Methylprednisolone—psoriatic arthritis	0.000325	0.00258	CcSEcCtD
Cephalexin—Convulsion—Methotrexate—psoriatic arthritis	0.000323	0.00256	CcSEcCtD
Cephalexin—Dyspepsia—Prednisone—psoriatic arthritis	0.00032	0.00254	CcSEcCtD
Cephalexin—Arthralgia—Methotrexate—psoriatic arthritis	0.000317	0.00252	CcSEcCtD
Cephalexin—Rash—Prednisolone—psoriatic arthritis	0.000316	0.00251	CcSEcCtD
Cephalexin—Dermatitis—Prednisolone—psoriatic arthritis	0.000315	0.0025	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000315	0.0025	CcSEcCtD
Cephalexin—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000314	0.00249	CcSEcCtD
Cephalexin—Fatigue—Prednisone—psoriatic arthritis	0.000314	0.00249	CcSEcCtD
Cephalexin—Headache—Prednisolone—psoriatic arthritis	0.000314	0.00249	CcSEcCtD
Cephalexin—Confusional state—Methotrexate—psoriatic arthritis	0.000307	0.00243	CcSEcCtD
Cephalexin—Dizziness—Triamcinolone—psoriatic arthritis	0.000305	0.00242	CcSEcCtD
Cephalexin—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000304	0.00241	CcSEcCtD
Cephalexin—Dizziness—Methylprednisolone—psoriatic arthritis	0.000304	0.00241	CcSEcCtD
Cephalexin—Feeling abnormal—Prednisone—psoriatic arthritis	0.0003	0.00238	CcSEcCtD
Cephalexin—Asthenia—Betamethasone—psoriatic arthritis	0.0003	0.00238	CcSEcCtD
Cephalexin—Asthenia—Dexamethasone—psoriatic arthritis	0.0003	0.00238	CcSEcCtD
Cephalexin—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000298	0.00237	CcSEcCtD
Cephalexin—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000298	0.00236	CcSEcCtD
Cephalexin—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000298	0.00236	CcSEcCtD
Cephalexin—Nausea—Prednisolone—psoriatic arthritis	0.000297	0.00236	CcSEcCtD
Cephalexin—Pruritus—Dexamethasone—psoriatic arthritis	0.000296	0.00235	CcSEcCtD
Cephalexin—Pruritus—Betamethasone—psoriatic arthritis	0.000296	0.00235	CcSEcCtD
Cephalexin—Skin disorder—Methotrexate—psoriatic arthritis	0.000295	0.00234	CcSEcCtD
Cephalexin—Vomiting—Triamcinolone—psoriatic arthritis	0.000293	0.00232	CcSEcCtD
Cephalexin—Vomiting—Methylprednisolone—psoriatic arthritis	0.000292	0.00232	CcSEcCtD
Cephalexin—Rash—Triamcinolone—psoriatic arthritis	0.00029	0.0023	CcSEcCtD
Cephalexin—Dermatitis—Triamcinolone—psoriatic arthritis	0.00029	0.0023	CcSEcCtD
Cephalexin—Rash—Methylprednisolone—psoriatic arthritis	0.00029	0.0023	CcSEcCtD
Cephalexin—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000289	0.0023	CcSEcCtD
Cephalexin—Urticaria—Prednisone—psoriatic arthritis	0.000289	0.00229	CcSEcCtD
Cephalexin—Headache—Triamcinolone—psoriatic arthritis	0.000288	0.00229	CcSEcCtD
Cephalexin—Headache—Methylprednisolone—psoriatic arthritis	0.000288	0.00228	CcSEcCtD
Cephalexin—Body temperature increased—Prednisone—psoriatic arthritis	0.000288	0.00228	CcSEcCtD
Cephalexin—Abdominal pain—Prednisone—psoriatic arthritis	0.000288	0.00228	CcSEcCtD
Cephalexin—Diarrhoea—Betamethasone—psoriatic arthritis	0.000286	0.00227	CcSEcCtD
Cephalexin—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000286	0.00227	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000277	0.0022	CcSEcCtD
Cephalexin—Dizziness—Betamethasone—psoriatic arthritis	0.000276	0.00219	CcSEcCtD
Cephalexin—Dizziness—Dexamethasone—psoriatic arthritis	0.000276	0.00219	CcSEcCtD
Cephalexin—Nausea—Triamcinolone—psoriatic arthritis	0.000274	0.00217	CcSEcCtD
Cephalexin—Nausea—Methylprednisolone—psoriatic arthritis	0.000273	0.00217	CcSEcCtD
Cephalexin—Hypersensitivity—Prednisone—psoriatic arthritis	0.000268	0.00213	CcSEcCtD
Cephalexin—Dyspepsia—Methotrexate—psoriatic arthritis	0.000268	0.00212	CcSEcCtD
Cephalexin—Vomiting—Dexamethasone—psoriatic arthritis	0.000266	0.00211	CcSEcCtD
Cephalexin—Vomiting—Betamethasone—psoriatic arthritis	0.000266	0.00211	CcSEcCtD
Cephalexin—Rash—Betamethasone—psoriatic arthritis	0.000263	0.00209	CcSEcCtD
Cephalexin—Rash—Dexamethasone—psoriatic arthritis	0.000263	0.00209	CcSEcCtD
Cephalexin—Dermatitis—Dexamethasone—psoriatic arthritis	0.000263	0.00209	CcSEcCtD
Cephalexin—Dermatitis—Betamethasone—psoriatic arthritis	0.000263	0.00209	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000263	0.00208	CcSEcCtD
Cephalexin—Fatigue—Methotrexate—psoriatic arthritis	0.000262	0.00208	CcSEcCtD
Cephalexin—Headache—Dexamethasone—psoriatic arthritis	0.000262	0.00208	CcSEcCtD
Cephalexin—Headache—Betamethasone—psoriatic arthritis	0.000262	0.00208	CcSEcCtD
Cephalexin—Asthenia—Prednisone—psoriatic arthritis	0.000261	0.00207	CcSEcCtD
Cephalexin—Pruritus—Prednisone—psoriatic arthritis	0.000257	0.00204	CcSEcCtD
Cephalexin—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000251	0.00199	CcSEcCtD
Cephalexin—Diarrhoea—Prednisone—psoriatic arthritis	0.000249	0.00198	CcSEcCtD
Cephalexin—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000249	0.00197	CcSEcCtD
Cephalexin—Nausea—Dexamethasone—psoriatic arthritis	0.000248	0.00197	CcSEcCtD
Cephalexin—Nausea—Betamethasone—psoriatic arthritis	0.000248	0.00197	CcSEcCtD
Cephalexin—Urticaria—Methotrexate—psoriatic arthritis	0.000242	0.00192	CcSEcCtD
Cephalexin—Dizziness—Prednisone—psoriatic arthritis	0.000241	0.00191	CcSEcCtD
Cephalexin—Body temperature increased—Methotrexate—psoriatic arthritis	0.00024	0.00191	CcSEcCtD
Cephalexin—Abdominal pain—Methotrexate—psoriatic arthritis	0.00024	0.00191	CcSEcCtD
Cephalexin—Vomiting—Prednisone—psoriatic arthritis	0.000231	0.00184	CcSEcCtD
Cephalexin—Rash—Prednisone—psoriatic arthritis	0.000229	0.00182	CcSEcCtD
Cephalexin—Dermatitis—Prednisone—psoriatic arthritis	0.000229	0.00182	CcSEcCtD
Cephalexin—Headache—Prednisone—psoriatic arthritis	0.000228	0.00181	CcSEcCtD
Cephalexin—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000224	0.00178	CcSEcCtD
Cephalexin—Asthenia—Methotrexate—psoriatic arthritis	0.000218	0.00173	CcSEcCtD
Cephalexin—Nausea—Prednisone—psoriatic arthritis	0.000216	0.00171	CcSEcCtD
Cephalexin—Pruritus—Methotrexate—psoriatic arthritis	0.000215	0.00171	CcSEcCtD
Cephalexin—Diarrhoea—Methotrexate—psoriatic arthritis	0.000208	0.00165	CcSEcCtD
Cephalexin—Dizziness—Methotrexate—psoriatic arthritis	0.000201	0.0016	CcSEcCtD
Cephalexin—Vomiting—Methotrexate—psoriatic arthritis	0.000193	0.00153	CcSEcCtD
Cephalexin—Rash—Methotrexate—psoriatic arthritis	0.000192	0.00152	CcSEcCtD
Cephalexin—Dermatitis—Methotrexate—psoriatic arthritis	0.000192	0.00152	CcSEcCtD
Cephalexin—Headache—Methotrexate—psoriatic arthritis	0.000191	0.00151	CcSEcCtD
Cephalexin—Nausea—Methotrexate—psoriatic arthritis	0.000181	0.00143	CcSEcCtD
